Skip to main content

Table 4 Morality at 1 year after ICH onset

From: Can minimally invasive puncture and drainage for hypertensive spontaneous Basal Ganglia intracerebral hemorrhage improve patient outcome: a prospective non-randomized comparative study

  All patients n (%) Groups
     A (n = 84)   B (n = 114)   
  Dead Alive P Dead Alive Total Dead Alive Total P
  86 (43.4) 112 (56.6)   31 (36.1) 53 (63.9) 84 55 (48.2) 59 (51.8) 114 0.112
Age           0.112
60 50 (38.5) 80 (61.5) 0.052 11 (24.4) 34 (75.6) 45 39 (45.9) 46 (51.4) 85 0.017
 > 60 36 (52.9) 32 (47.1) 20 (51.3) 19 (48.7) 39 16 (55.2) 19 (48.7) 39 0.752
Gender           0.112
 Female 22 (40.7) 32 (59.3) 0.640 9 (40.9) 13 (59.1) 22 13 (40.6) 19 (59.4) 32 0.983
 Male 64 (44.4) 80 (55.6) 22 (35.5) 40 (64.5) 62 42 (51.2) 40 (48.8) 82 0.061
Diabetes           0.112
 No 48 (37.8) 79 (62.2) 0.033 18 (30.0) 42 (70.0) 60 30 (44.8) 37 (55.2) 67 0.088
 Yes 38 (53.5) 33 (46.5) 13 (54.2) 11 (45.8) 24 25 (53.2) 22 (46.8) 47 0.938
GCS    <0.001        0.147
 15-13 grade 1 3 (10.0) 27 (90.0)   0 (0.0) 17 (100.0) 17 3 (23.1) 10 (76.9) 13 0.070
 12-7 grade 2 29 (33.0) 59 (67.0) 0.017a 8 (21.6) 29 (78.4) 37 21 (41.2) 30 (58.8) 51 0.055
 6-3 grade 3 54 (67.5) 26 (32.5) <0.001b 23 (76.7) 7 (23.3) 30 31 (62.0) 19 (38.0) 50 0.178
NIHSS    <0.001        0.147
 <15 grade 1 5 (15.6) 27 (84.4)   0 (0.0) 17 (100.0) 17 5 (33.3) 10 (66.7) 15 0.015
 15-20 grade 2 14 (28.0) 36 (72.0) 0.284a 4 (18.2) 18 (81.8) 22 10 (35.7) 18 (64.3) 28 0.175
 >20 grade 3 67 (57.8) 49 (42.2) <0.001b 27 (60.0) 18 (40.0) 45 40 (56.3) 31 (43.7) 71 0.698
HV, mL           0.112
60 41 (31.3) 90 (68.7) <0.001 13 (21.3) 48 (78.7) 61 28 (40.0) 42 (60.0) 70 0.022
 > 60 45 (67.2) 22 (32.8) 18 (78.3) 5 (21.7) 23 27 (61.4) 17 (38.6) 44 0.165
IVH    <0.001        0.147
0 16 (25.0) 48 (75.0) 0.918c 3 (10.0) 27 (90.0) 30 13 (38.2) 21 (61.8) 34 0.010
 1-4 16 (25.8) 46 (74.2) 5 (18.5) 22 (81.5) 27 11 (31.4) 24 (68.6) 35 0.253
 5-8 27 (75.0) 9 (25.0) <0.001a 11 (73.3) 4 (26.7) 15 16 (76.2) 5 (23.8) 21 1.000
 9-12 27 (75.0) 9 (25.0) 1.000b 12 (100.0) 0 (0.0) 12 15 (62.5) 9 (37.5) 24 0.036
Complications, n (%)          
RB           0.147
 No 79 (41.8) 110 (58.2) 0.042 30 (36.1) 53 (63.9) 83 49 (46.2) 57 (53.8) 106 0.164
 Yes 7 (77.8) 2 (22.2) 1 (100.0) 0 1 6 (75.0) 2 (25.0) 8 1.000
RF           0.147
 NO 68 (38.4) 109 (61.6) <0.001 26 (32.9) 53 (67.1) 79 42 (42.9) 56 (57.1) 98 0.177
 Yes 18 (85.7) 3 (14.3)   5 (100.0) 0 5 13 (81.3) 3 (18.8) 16 0.549
PI           0.147
 No 38 (32.8) 78 (67.2) <0.001 13 (26.0) 37 (74.0) 50 25 (37.9) 41 (62.1) 66 0.179
 Yes 48 (58.5) 34 (41.5)   18 (52.9) 16 (47.1) 34 30 (62.5) 18 (37.5) 48 0.496
UGB          0.147
 No 75 (41.0) 108 (59.0) 0.027 25 (32.5) 52 (67.5) 77 50 (47.2) 56 (52.8) 106 0.046
 Yes 11 (73.3) 4 (26.7) 6 (85.7) 1 (14.3) 7 5 (62.5) 3 (37.5) 8 0.569
  1. P values were calculated using the Wilcoxon or Kruskal-Wallis rank sum tests. Groups: A, minimal invasive puncture and drainage; B, decompressive craniectomy; BP: blood pressure; SPB systolic blood pressure. DBP: diastolic blood pressure. GCS: Glasgow Coma Scale; NIHSS: National Institutes of Health Stroke Scale; HV: hematoma volume; IVH: intraventricular hemorrhage; RB: rebleed; PI: pulmonary infection; RF: renal failure; UGB: upper gastrointestinal bleeding; agrade 1 vs. grade 2; bgrade 2 vs. grade 3; cIVH 0 vs. IVH grade 1.